This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

LSX USA Congress
Life Science Executive Partnering
Congress Sept 16-17, Forums Sept 15, 2025Thomas Michael Menino Convention & Exhibition Center, Boston, USA
Tickets
Menu
Tickets
Key Sessions
Michelle Li
Strategic Alliances in Biopharma: Unlocking Growth Through Collaborative Partnerships
Bristol Myers Squibb
Funding the Future: How Strategic CMOs Drive Investment Success in Biotech
Michaela Tolman
Rewiring the Future: Innovations Driving Progress in Neuroscience Across Life Sciences
Pfizer
Greg Greifeld
Venture Debt: The Non-Dilutive Edge
Runway Growth Capital
Irene Blat
Next-Gen Oncology: Partnering for Progress to Bring New Therapies to Market
Servier Pharmaceuticals
Kurt Haggstrom
Putting the Tech in Medtech: How Big Tech are Staking Their Claim in the Healthcare Sector
Synchron
Christopher Tan
From Spark to Success: Partnering in Early-Stage Pharma Innovation
Merck
Jim Robertson
The Future of Neuromodulation is Here: The Partnership Between Neuroscience and Neurotechnology
Nu-Life Solutions
keyboard_arrow_right

Day 2 – Wednesday, 17 Sept 2025 - ET (Eastern Time, GMT-05:00)

keyboard_arrow_leftSearch & Filter
search
Day 2 – Wednesday, 17 Sept 2025 - ET (Eastern Time, GMT-05:00)
search
8:00am - 8:55am
Registration & Breakfast
Showing 2 of 2 Streams
8:55am - 9:00am
LSX Welcome Address
9:00am - 9:50am
Strategic Alliances in Biopharma: Unlocking Growth Through Collaborative Partnerships
  • Michelle Li - Vice President and Head, BD&L Transactions, Bristol Myers Squibb
  • Aaron Gardner - Partner, Latham & Watkins
  • Philippe Lopes-Fernandes - EVP, Chief Business Officer, IPSEN
  • Siobhan Pomeroy - VP, Corporate Development, Gilead Sciences
9:50am - 10:30am
The Future of Chronic Pain Treatment
  • Clemens Fischer - Founder & Chairman, VERTANICAL GmbH
8:55am - 9:00am
LSX Welcome Address
9:00am - 9:50am
Putting the Tech in Medtech: How Big Tech are Staking Their Claim in the Healthcare Sector
  • Kurt Haggstrom - CCO, Synchron
  • Carolina Aguilar - CEO & Co-Founder, INBRAIN Neuroelectronics
9:50am - 10:30am
The Future of Neuromodulation is Here: The Partnership Between Neuroscience and Neurotechnology
  • Jim Robertson - CEO, Nu-Life Solutions
10:30am - 11:00am
MORNNG BREAK
Showing 4 of 4 Streams
11:00am - 11:50am
Smart Capital: Rethinking Biotech Fundraising for Agility and Survival
  • Niranjan Sardesai - President & CEO, Founder, Geneos Therapeutics
  • Anula Jayasuriya - Co-Founder, Kidron Capital
  • Sohail Zaidi - CEO, Ananda Scientific Inc
  • Elena Itskovich - Founding General Partner, Nest Catalyst Ventures
11:50am - 12:40pm
Funding the Future: How Strategic CMOs Drive Investment Success in Biotech

In today's capital-constrained biotech landscape, the Chief Medical Officer's role has evolved into a critical driver of fundraising success. Beyond clinical oversight, today's CMOs must effectively translate scientific progress into compelling investment narratives while building efficient medical functions that maximize runway. This panel explores how modern CMOs can directly impact valuation, investor confidence, and capital efficiency through strategic leadership.

  • CMOs as Fundraising Catalysts: Leveraging clinical expertise to strengthen investor pitches, validate development strategies, and build credibility with financial stakeholders.
  • Building Capital-Efficient R&D: Designing medical functions that balance immediate needs with future scalability, ensuring optimal resource allocation throughout the fundraising lifecycle.
  • Fractional Leadership Models: Implementing flexible medical leadership structures that provide world-class expertise while preserving capital during critical fundraising periods.
12:40pm - 1:20pm
Venture Debt: The Non-Dilutive Edge
  • Greg Greifeld - Chief Investment Officer, Runway Growth Capital
  • Ryan Kaeding - Managing Director, Life Sciences, Trinity Capital
  • Jeff Becker - Managing Director, Avenue Capital
11:00am - 11:50am
Next-Gen Oncology: Partnering for Progress to Bring New Therapies to Market
  • Irene Blat - Senior Director, Search & Evaluation, Servier Pharmaceuticals
  • Joel Klappenbach - Executive Director, Oncology Business Development, Pfizer
  • Venky Raghavan - Executive Director, Search & Evaluation, Oncology, Novartis
11:50am - 12:40pm
From Spark to Success: Partnering in Early-Stage Pharma Innovation
  • Christopher Tan - Executive Director, BD&L, Merck
  • Mankit Law - Senior Director – BD, Search & Evaluation, GSK
  • Jeremy O’Hanlon - Executive Director, Global BD, Daiichi-Sankyo
11:00am - 11:50am
Biotech in 2025: Rethinking Early Commercialisation for a Rapidly Changing Market
  • Tim Sullivan - CBO, Infinimmune
  • Andy Tincu - VP, Solutions Development, Syneos Health
  • Raven Lin - CEO, Pilatus Biosciences
  • David Brower - Vice President & Head of Business Development, Accent Therapeutics
  • Michelle Chen - Chief Business Officer, Insilico Medicine
  • Minji Kim - CBO, Mineralys Tx
11:50am - 12:40pm
Platforms, Not Products: Unlocking the Next Wave of Biotech Innovation
  • Amber Salzman - CEO, Epicrispr
  • Jae Won Kim - COO/CFO, VantAI
  • Lihua Zheng - CEO, Z-Star Therapeutics
12:40pm - 1:20pm
The Equation for Maturation: Biotech Requirements to Achieve Scale
  • Rachel Ravens - CEO, 42Genetics
  • Jukka Muhonen - VP Business Development, Orphagen Pharmaceuticals
  • John Harlow - Chief Commercial Officer, Melinta Therapeutics
11:00am - 11:50am
Flipping the Script: How Medtech is Responding to the Rise of Techmed
  • Sean Cheng - Managing Director, Head of Medtech & Life Sciences, Ascension Ventures
  • David Zakariaie - CEO & Founder, Senseye
  • Alan Cohen - General Partner, DCVC
  • Amir Zur - Executive Director, Regional Head of R&D Engineering, Digital Unit, Olympus Corporation
11:50am - 12:40pm
Going Global: The Realities of Expanding into New Markets
  • Mike Alvarez - CEO, Glooko
  • Chris Springate - CEO, ARC Medical
12:40pm - 1:20pm
Unlocking Strategic Partnerships: How To Engage Tier 1 Medtech and Pharma’s Biggest Players
  • Nate Harrington - Managing Partner, Philips Ventures
  • Ilana Gotlib - Senior Director, Strategy & Business Development, Stryker
  • Jim Parshall - Executive Director, Drug Delivery R&D, Eli Lilly and Company
1:20pm - 2:20pm
LUNCH BREAK
Showing 1 of 1 Streams
2:20pm - 3:10pm
Uncommon Minds, Unseen Opportunities: How Diversity in Thought Brings New Medicines and Technologies to Market
  • Steven Fuller - Founder & Director, Race in STEM
  • Leslie Sam - President, Leslie Sam & Associates
3:10pm - 4:00pm
Rewiring the Future: Innovations Driving Progress in Neuroscience Across Life Sciences
  • Michaela Tolman - Senior Director, Commercial Planning, Pfizer
  • David Donabedian - Executive Partner, Longwood Fund
  • Christian Howell - CEO, Cognito Therapeutics
  • Marc Jones - CEO, Altoida
4:00pm - 4:05pm
Close of Congress
Pharma BD Leaders Forum
NextDay 2 Showcases
Filter
Streams
Formats
Choose Day